EMMI, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.965
EU - Europa 5.970
AS - Asia 1.280
SA - Sud America 8
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 16.233
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.938
PL - Polonia 2.024
IE - Irlanda 1.193
IT - Italia 1.134
SE - Svezia 780
HK - Hong Kong 575
CN - Cina 311
JO - Giordania 203
CH - Svizzera 180
RU - Federazione Russa 158
GB - Regno Unito 126
DE - Germania 114
VN - Vietnam 70
ES - Italia 56
AT - Austria 55
FI - Finlandia 44
TR - Turchia 36
UA - Ucraina 33
FR - Francia 29
CA - Canada 26
IN - India 23
SG - Singapore 23
BE - Belgio 17
SA - Arabia Saudita 14
DK - Danimarca 11
NL - Olanda 9
IL - Israele 7
IR - Iran 7
PE - Perù 5
BR - Brasile 3
GR - Grecia 3
JP - Giappone 3
PS - Palestinian Territory 3
SC - Seychelles 3
EU - Europa 2
ID - Indonesia 2
KR - Corea 2
MU - Mauritius 2
NG - Nigeria 2
AU - Australia 1
CZ - Repubblica Ceca 1
MK - Macedonia 1
MX - Messico 1
NO - Norvegia 1
RO - Romania 1
TW - Taiwan 1
Totale 16.233
Salva come PNG Salva come JPEG
Città #
Warsaw 2.021
Fairfield 1.530
Dublin 1.191
Chandler 858
Ashburn 796
Woodbridge 661
Seattle 582
Houston 538
Cambridge 518
Wilmington 425
Lawrence 404
Altamura 358
Hong Kong 344
Princeton 282
Florence 223
Ann Arbor 214
Boston 213
Beijing 177
Bern 175
Buffalo 152
Moscow 146
San Diego 117
New York 114
Medford 98
Boardman 74
Shanghai 74
Dong Ket 58
Vienna 55
Falls Church 54
Norwalk 50
Barcelona 46
Hillsboro 36
London 31
Redwood City 29
Milan 25
Rome 25
Castelliri 23
Toronto 23
Andover 20
Washington 18
Brussels 17
Guangzhou 17
Singapore 17
Jacksonville 15
Phoenix 14
Pune 12
Copenhagen 11
Kilburn 11
Bari 10
Bologna 10
Dearborn 10
Genoa 9
Napoli 9
Paris 9
Redmond 9
Arezzo 7
Campi Bisenzio 7
Laurel 7
Nanjing 7
New Bedfont 6
Old Bridge 6
Perugia 6
Riyadh 6
Rolla 6
Siena 6
Cerignola 5
Hangzhou 5
Inverurie 5
Jinan 5
Khobar 5
Lima 5
Padova 5
Trumbull 5
Cagliari 4
Chicago 4
Empoli 4
Hounslow 4
Izmir 4
Mumbai 4
Naaldwijk 4
Palermo 4
Prescot 4
Saint-Fons 4
Taiyuan 4
Tel Aviv 4
Timonium 4
Verona 4
Altidona 3
Atlanta 3
Bilbao 3
Duncan 3
Helsinki 3
Insch 3
Istanbul 3
Leeds 3
Monmouth Junction 3
Naples 3
Palagiano 3
Parma 3
Rieti 3
Totale 13.157
Salva come PNG Salva come JPEG
Nome #
Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease 268
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 238
An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions. 228
Behçet's syndrome patients exhibit specific microbiome signature. 227
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 207
Repeated low-dose courses of rituximab in SLE-associated antiphospholipid syndrome: Data from a tertiary dedicated centre 205
SIRT1 activity is decreased in lesional psoriatic skin 205
Central vein sign differentiates MS from CNS inflammatory vasculopathies. 199
Digital ulcers secondary to Sneddon's syndrome successfully treated with Bosentan: not only useful in Systemic Sclerosis 193
Sirt1 Protects against Oxidative Stress-Induced Apoptosis in Fibroblasts from Psoriatic Patients: A New Insight into the Pathogenetic Mechanisms of Psoriasis 169
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 161
A biochemical approach to detect oxidative stress in infertile women undergoing assisted reproductive technology procedures 150
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 137
Behcet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils 129
First report of FIP1L1-PDGFR alpha-positive eosinophilic granulomatosis with polyangiitis 126
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 126
Thrombosis in vasculitis: from pathogenesis to treatment 122
ANCA-associated vasculitis in childhood: Recent advances 122
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. 119
Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment 113
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 106
Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report 104
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet’s Disease 103
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 101
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 100
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 100
Role of polymorphonucleates in the pathogenesis of systemic juvenile idiopathic arthritis and Still's disease: A proof of concept study 99
Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress 97
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 97
Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome 97
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 96
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 95
Cardiac involvement in Churg Strauss syndrome: an update on cardiological manifestations 93
Intravenous immunoglobulin therapy: a snapshot for the internist. 93
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 91
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? 91
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 91
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 90
Thrombosis in inflammatory bowel diseases: What's the link? 89
Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects 89
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis 88
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 87
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 86
Pulmonary hemorrhage: not only vasculitis. 85
Redox status alterations during the competitive season in élite soccer players: focus on peripheral leukocyte-derived ROS 85
Pathogenesis of Behcet Syndrome 83
Brief Report: Rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schönlein purpura) 83
Lobular panniculitis with small vessel vasculitis associated with ulcerative colitis. 82
Erythrocyte membrane fluidity alterations in sudden sensorineural hearing loss patients: The role of oxidative stress 82
A case of lichenoid drug eruption associated with subcutaneous immunoglobulin therapy. 81
Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature 80
The "multifaceted" onset of vasculitis neuropathy 79
The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit 78
Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome 77
Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets 76
Cytomegalovirus retinitis following intravitreal dexamethasone implant in a patient with central retinal vein occlusion 76
Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experience 76
Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma 76
The risk stratification in atrial fibrillation 74
The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy 74
CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis 74
Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: An uncommon adverse effect? 73
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 73
Sharing data of clinical trials 72
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry 72
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study 71
The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. 71
Vascular Behçet's syndrome: an update 70
The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies 70
OP0148 MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS 70
An immune-molecular hypothesis supporting infectious aetiopathogenesis of Kawasaki disease in children 69
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 69
Significance of PR3-ANCA Positivity in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) 69
Rapid desensitization to anakinra-related delayed reaction: Need for a standardized protocol 68
Kimura’s disease: case report of an Italian young male and response to oral cyclosporine A in an 8 years follow-up 67
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 67
A TNFSF13B Functional Variant Is Not Involved in Systemic Sclerosis and Giant Cell Arteritis Susceptibility 66
Infliximab and Cogan's syndrome 65
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 65
The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review 65
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 65
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet's phenotype: A multicentre study 64
New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy 64
Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study 64
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 64
Anakinra for resistant Behçet uveitis: why not? 63
Pharmacological prevention of venous thromboembolism in orthopaedic surgery 62
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 62
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 62
Helicobacter pylori management in primary care. 61
Microparticles: Bridging the gap between autoimmunity and thrombosis 61
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 61
Modulation of gut microbiota through nutritional interventions in Behçet’s syndrome patients (the MAMBA study): study protocol for a randomized controlled trial 61
Prognostic Value of Degree and Types of Anaemia on Clinical Outcomes for Hospitalised Older Patients 60
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 60
Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study 59
Reply: anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series 59
Behçet's disease as a cause of cerebral sinus vein thrombosis: an emerging role 59
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 59
null 59
Totale 9.589
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.908
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019718 0 0 0 0 0 0 0 0 0 157 300 261
2019/20202.903 150 156 64 177 330 317 336 341 333 238 244 217
2020/20212.826 157 263 102 470 243 217 226 170 311 347 149 171
2021/20221.971 56 75 235 74 51 130 51 216 125 82 284 592
2022/20235.098 453 1.108 268 222 221 883 686 268 500 63 181 245
2023/20242.096 93 172 344 162 164 353 130 488 80 110 0 0
Totale 16.705